Xagrid



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 49.2%
Essential Thrombocythaemia 31.3%
Thrombocytosis 5.1%
Hypertension 3.0%
Myelofibrosis 1.3%
Bronchitis 1.0%
Myeloproliferative Disorder 1.0%
Prophylaxis 1.0%
Thrombocytopenia 1.0%
Bronchitis Chronic 0.7%
Chronic Obstructive Pulmonary Disease 0.7%
Diabetes Mellitus 0.7%
Peripheral Arterial Occlusive Disease 0.7%
Pulmonary Embolism 0.7%
Renal Failure 0.7%
Thrombosis 0.7%
Angina Pectoris 0.3%
Anxiety Disorder 0.3%
Arrhythmia 0.3%
Atrial Fibrillation 0.3%
Myelofibrosis 10.9%
Breast Cancer 6.5%
Coronary Artery Disease 6.5%
Gastrointestinal Haemorrhage 6.5%
Myocardial Infarction 6.5%
Rectal Haemorrhage 6.5%
Thrombocytopenia 6.5%
Hospitalisation 4.3%
Hypertension 4.3%
Palpitations 4.3%
Platelet Count Increased 4.3%
Pulmonary Oedema 4.3%
Skin Ulcer 4.3%
Splenic Vein Thrombosis 4.3%
Syncope 4.3%
Transient Ischaemic Attack 4.3%
Vomiting 4.3%
Acute Coronary Syndrome 2.2%
Acute Myocardial Infarction 2.2%
Angina Pectoris 2.2%
Secondary
Product Used For Unknown Indication 33.2%
Essential Thrombocythaemia 20.1%
Hypertension 11.7%
Breast Cancer 7.0%
Thrombocytosis 4.2%
Hypercholesterolaemia 3.4%
Myelofibrosis 2.1%
Prostate Cancer 2.1%
Drug Use For Unknown Indication 1.8%
Bronchitis Chronic 1.6%
Embolic Stroke 1.6%
Prophylaxis 1.6%
Thromboembolic Stroke 1.6%
Thrombosis 1.6%
Breast Cancer Female 1.3%
Cerebrovascular Accident 1.0%
Chronic Obstructive Pulmonary Disease 1.0%
Osteoporosis Prophylaxis 1.0%
Peripheral Arterial Occlusive Disease 1.0%
Thrombocythaemia 1.0%
Renal Failure 12.7%
Palpitations 10.9%
Oesophagitis 7.3%
Transient Ischaemic Attack 7.3%
Lung Infection 5.5%
Malignant Neoplasm Progression 5.5%
Skin Ulcer 5.5%
Tachycardia 5.5%
Ventricular Extrasystoles 5.5%
White Blood Cell Count Decreased 5.5%
Acute Coronary Syndrome 3.6%
Acute Myeloid Leukaemia 3.6%
Pancytopenia 3.6%
Pulmonary Arterial Hypertension 3.6%
Syncope 3.6%
Viral Infection 3.6%
Asthenia 1.8%
Bronchioloalveolar Carcinoma 1.8%
Cerebral Haemorrhage 1.8%
Condition Aggravated 1.8%
Concomitant
Bipolar Disorder 17.6%
Chronic Myeloid Leukaemia 11.8%
Essential Thrombocythaemia 11.8%
Autoimmune Thyroiditis 5.9%
Bipolar I Disorder 5.9%
Cardiovascular Disorder 5.9%
Hepatitis B 5.9%
Hypertension 5.9%
Interstitial Lung Disease 5.9%
Mania 5.9%
Myelofibrosis 5.9%
Thrombocythaemia 5.9%
Thrombocytosis 5.9%
Weight Increased 28.6%
Pancreatitis Acute 14.3%
Renal Failure 14.3%
Tachycardia 14.3%
Urinary Retention 14.3%
Vertigo 14.3%